Two CHOP Patients With an Inherited Blindness Successfully Treated With Gene Editing
May 07, 2024
May 07, 2024
PHILADELPHIA, Pennsylvania, May 7 (TNSres) -- Children's Hospital of Philadelphia issued the following news on May 6, 2024:
A multi-institutional clinical trial involving researchers from Children's Hospital of Philadelphia (CHOP) and the Scheie Eye Institute at the University of Pennsylvania found that CRISPR-Cas9 gene editing delivered to fourteen individuals with a form of inherited blindness was safe and led to measurable improvements in vision in nearly half of the of . . .
A multi-institutional clinical trial involving researchers from Children's Hospital of Philadelphia (CHOP) and the Scheie Eye Institute at the University of Pennsylvania found that CRISPR-Cas9 gene editing delivered to fourteen individuals with a form of inherited blindness was safe and led to measurable improvements in vision in nearly half of the of . . .